Author

Federico Bertoletti

EFFICACY OF BIOLOGICAL THERAPY FOR POUCHITIS AND OTHER INFLAMMATORY COMPLICATIONS OF THE POUCH, AND THE QUESTION OF A SECOND ANTI-TNF AFTER ANTI-TNF FAILURE? RESULTS FROM THE RESERVO STUDY OF GETECCU
EFFICACY OF BIOLOGICAL THERAPY FOR POUCHITIS AND OTHER INFLAMMATORY COMPLICATIONS OF THE POUCH, AND THE QUESTION OF A SECOND ANTI-TNF AFTER ANTI-TNF FAILURE? RESULTS FROM THE RESERVO STUDY OF GETECCU

Federico Bertoletti  et al.

INFLAMMATORY COMPLICATIONS OF THE POUCH, AND THERAPEUTIC REQUIREMENTS AFTER COLECTOMY IN PATIENTS WITH ULCERATIVE COLITIS. RESULTS FROM THE RESERVO STUDY OF GETECCU
INFLAMMATORY COMPLICATIONS OF THE POUCH, AND THERAPEUTIC REQUIREMENTS AFTER COLECTOMY IN PATIENTS WITH ULCERATIVE COLITIS. RESULTS FROM THE RESERVO STUDY OF GETECCU

Federico Bertoletti  et al.

IMMUNOSUPPRESSIVE TREATMENT IS NOT A RISK FACTOR TO DEVELOP A WORSE SARS-COV-2 INFECTION IN ELDERLY IBD PATIENTS. AN OBSERVATIONAL, DESCRIPTIVE, COHORT STUDY
IMMUNOSUPPRESSIVE TREATMENT IS NOT A RISK FACTOR TO DEVELOP A WORSE SARS-COV-2 INFECTION IN ELDERLY IBD PATIENTS. AN OBSERVATIONAL, DESCRIPTIVE, COHORT STUDY

Federico Bertoletti  et al.

USE OF MYCOPHENOLATE MOFETIL IN INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE ENEIDA REGISTRY
USE OF MYCOPHENOLATE MOFETIL IN INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE ENEIDA REGISTRY

Federico Bertoletti  et al.

Item 1 - 4 / 4
1